Jeremiah Kim
AeroLeads people directory · profile

Jeremiah Kim Email & Phone Number

Co-Founder and CSO at Signl
Location: Greater Chicago Area, United States 6 work roles 2 schools
LinkedIn matched
✓ Verified July 2026 3 data sources Profile completeness 86%

Contact Signals

LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Signl
Role
Co-Founder and CSO
Location
Greater Chicago Area, United States

Who is Jeremiah Kim? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Jeremiah Kim is listed as Co-Founder and CSO at Signl, based in Greater Chicago Area, United States. AeroLeads shows a matched LinkedIn profile for Jeremiah Kim.

Jeremiah Kim previously worked as Co-Founder / CSO at Signl and Immunoengineering PhD Candidate, Aaron Esser-Kahn Research Group at University Of Chicago. Jeremiah Kim holds Doctor Of Philosophy - Phd, Molecular Engineering from University Of Chicago.

Profile bio

About Jeremiah Kim

Having a deep appreciation for how research drives meaningful medical innovations, I am working on translating my work into the real world with my start-up, Signl. I am using my previous research work on nanoparticle biosensors in Professor Emily Weiss’s lab at Northwestern to contribute to translational large scale Immunoengineering projects with Professor Esser-Kahn at UChicago's Molecular Engineering department. I led a high throughput screening project to discover adjuvants that improve vaccines. We identified a landscape of immunomodulators that can greatly enhance or inhibit specific cytokines and cell surface makers while increasing antibody generation in multiple commercial vaccine models (Flu, HepB, Typhoid).

Current workplace

Jeremiah Kim's current company

Company context helps verify the profile and gives searchers a useful next step.

Signl
Signl
Co-Founder and CSO
Chicago, IL, US
6 roles

Jeremiah Kim work experience

A career timeline built from the work history available for this profile.

Co-Founder And Cso

Signl

Chicago, Il, Us

Co-Founder / Cso

Current
Signl

Chicago, Illinois, United States

Signl is a preclinical stage research pharmaceutical company to save lives by offering customized control over innate immune signaling. We first seek to make every vaccine safer and more effective. Our compounds mix with almost any partner’s vaccine, reduce adverse side effects (fever, soreness in shoulder, fatigue) and increase the vaccine’s overall protection and durability.

Mar 2024 - Present

Immunoengineering Phd Candidate, Aaron Esser-Kahn Research Group

• Led a large scale high throughput screen (N=120,000) in collaboration with nine Professors to identify adjuvants for novel modulation of innate immune pathways • Identified classes of immunomodulators that can decrease systemic inflammation post vaccine in murine models and can increase antibody generation across multiple pattern recognition receptors.• Designed and conducted a machine learning assisted adjuvants screen (N = 140,000) that is the first of its kind to iteratively mix in silico and in vitro screening.• Identified lead adjuvants that will be screened for efficacy in both Flu and SARS-CoV-2 vaccines

Sep 2019 - Mar 2024

Discovery Research Intern (Oncology/Adcs)

South San Francisco, California, United States

•Measured potency of 30+ compounds to work as new payloads for ADCs and saw nanomolar+ potency and greater potency than benchmark ADCs. Selected DCs to be used by cross functional teams for in vivo POC experiments.•Payload target engagement was confirmed. Successfully explored degradation of target enzymes for novel ADCs.

Jun 2023 - Sep 2023

Chemical Engineering Research Assistant, Andrew Lee Research Group

• Created nanoparticle probes for real-time monitoring of the acetylation of mitochondrial proteins• Designed and synthesized a biological-friendly quantum dot system to demonstrate reporting on Lys acetylation• Joint project with Weiss Group to create stable aqueous quantum dot sensing systems

Jun 2017 - Sep 2019

Physical Chemistry Research Assistant, Emily Weiss Research Group

Evanston, Il

• Executed independent project on sensing local pH with quantum dots • Synthesized quantum dot-ligand systems, characterized quantum dot surfaces, and studied the effects of fluorination on ligand shell permeability • Master's thesis titled: "A Nanoparticle Probe Utilizing Electrostatic Potential for the Dynamic Sensing of pH and Acetylation"

Jun 2016 - Sep 2019
2 education records

Jeremiah Kim education

Ba/Ms Dual Degree, Chemistry

Activities and Societies: Alumnae of Northwestern University Undergraduate Research Scholar • Asian American InterVarsity: Community.

FAQ

Frequently asked questions about Jeremiah Kim

Quick answers generated from the profile data available on this page.

What company does Jeremiah Kim work for?

Jeremiah Kim works for Signl.

What is Jeremiah Kim's role at Signl?

Jeremiah Kim is listed as Co-Founder and CSO at Signl.

Where is Jeremiah Kim based?

Jeremiah Kim is based in Greater Chicago Area, United States while working with Signl.

What companies has Jeremiah Kim worked for?

Jeremiah Kim has worked for Signl, University Of Chicago, Abbvie, and Northwestern University.

How can I contact Jeremiah Kim?

You can use AeroLeads to view verified contact signals for Jeremiah Kim at Signl, including work email, phone, and LinkedIn data when available.

What schools did Jeremiah Kim attend?

Jeremiah Kim holds Doctor Of Philosophy - Phd, Molecular Engineering from University Of Chicago.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.

People with similar names

Check these profiles if this is not the Jeremiah Kim you were looking for.

View similar profiles